| |
| |
|
| Insider
Information: |
Adelman Robert J |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
7,359,142 |
|
|
Indirect Shares
|
4,767,780 |
|
|
| Direct
Value |
$22,637,265 |
|
|
|
Indirect Value
|
$127 |
|
|
| Total
Shares |
12,126,922 |
|
|
| Total
Value |
$22,637,392 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
19
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
19
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-19.0
|
| Percentage
Gain/Loss : |
 -45.6%
|
-1,900.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
American Cryostem Corporation |
CRYO |
Director, 10% Owner |
2005-07-13 |
0 |
2005-07-19 |
1,231,936 |
Premium* |
|
|
Volcano Corp |
VOLC |
Director |
2006-06-20 |
0 |
2006-06-20 |
195,705 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
Director, 10% Owner |
2007-11-13 |
0 |
2008-11-14 |
3,340,139 |
Premium* |
|
|
Checkmate Pharmaceuticals, Inc. |
CMPI |
10% Owner |
2022-05-16 |
2,155,930 |
2020-08-11 |
0 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2021-10-25 |
2,443,421 |
2020-09-18 |
0 |
Premium* |
|
|
Impel Neuropharma Inc |
IMPL |
|
2021-04-27 |
2,759,791 |
2021-04-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-16 |
4 |
S |
$10.45 |
$1,001,100 |
D/D |
(95,800) |
2,155,930 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-13 |
4 |
S |
$10.45 |
$374,464 |
D/D |
(35,850) |
2,251,730 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-12 |
4 |
S |
$10.39 |
$1,294,313 |
D/D |
(124,525) |
2,287,580 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-11 |
4 |
S |
$10.38 |
$183,641 |
D/D |
(17,700) |
2,412,105 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-10 |
4 |
S |
$10.38 |
$193,870 |
D/D |
(18,676) |
2,429,805 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-09 |
4 |
S |
$10.37 |
$182,582 |
D/D |
(17,600) |
2,448,481 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-06 |
4 |
S |
$10.37 |
$501,233 |
D/D |
(48,334) |
2,466,081 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-05 |
4 |
S |
$10.37 |
$215,105 |
D/D |
(20,743) |
2,514,415 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-04 |
4 |
S |
$10.37 |
$388,924 |
D/D |
(37,500) |
2,535,158 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-03 |
4 |
S |
$10.37 |
$824,434 |
D/D |
(79,475) |
2,572,658 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-05-02 |
4 |
S |
$10.38 |
$1,595,975 |
D/D |
(153,700) |
2,652,133 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-29 |
4 |
S |
$10.38 |
$718,663 |
D/D |
(69,230) |
2,805,833 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-28 |
4 |
S |
$10.38 |
$761,936 |
D/D |
(73,400) |
2,875,063 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-27 |
4 |
S |
$10.38 |
$491,980 |
D/D |
(47,396) |
2,948,463 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-26 |
4 |
S |
$10.38 |
$671,558 |
D/D |
(64,683) |
2,995,859 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-25 |
4 |
S |
$10.39 |
$287,404 |
D/D |
(27,668) |
3,060,542 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-22 |
4 |
S |
$10.39 |
$388,834 |
D/D |
(37,430) |
3,088,210 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-21 |
4 |
S |
$10.38 |
$645,866 |
D/D |
(62,200) |
3,125,640 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-20 |
4 |
S |
$10.39 |
$889,387 |
D/D |
(85,611) |
3,187,840 |
0 |
% |
|
| CMPI |
Checkmate Pharmaceuticals... |
10% Owner |
– – • |
2022-04-19 |
4 |
S |
$10.42 |
$4,165,238 |
D/D |
(399,923) |
3,273,451 |
0 |
% |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2021-10-25 |
4 |
S |
$1.49 |
$805,972 |
D/D |
(540,667) |
2,443,421 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
10% Owner |
– – • |
2021-10-22 |
4 |
S |
$1.64 |
$122,930 |
D/D |
(75,035) |
2,984,088 |
0 |
- |
|
| IMPL |
Impel Neuropharma Inc |
|
• • • |
2021-04-27 |
4 |
B |
$15.00 |
$6,750,000 |
D/D |
450,000 |
2,759,791 |
0.01 |
- |
|
| IMPL |
Impel Neuropharma Inc |
|
• • • |
2021-04-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,309,791 |
2,309,791 |
0 |
- |
|
| MTCR |
Metacrine, Inc. |
|
• • • |
2020-09-18 |
4 |
B |
$13.00 |
$2,990,000 |
D/D |
230,000 |
230,000 |
0.01 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
